Old Web
English
Sign In
Acemap
>
authorDetail
>
Mohamed Hegazi
Mohamed Hegazi
University of Louisville
Antigen
Venetoclax
MCL1
Cell
Refractory
1
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (1)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
AML-253: Trials in Progress: A Phase I/II Study of Venetoclax and Lintuzumab-Ac225 in Patients with Refractory or Relapsed AML
2020
Clinical Lymphoma, Myeloma & Leukemia
Mohamed Hegazi
Laura Finn
Gail J. Roboz
John G. Harpel
Gary J. Schiller
Show All
Source
Cite
Save
Citations (0)
1